Dr Antonia Roseweir

  • Lecturer in Surgery (School of Medicine, Dentistry & Nursing)
  • Visiting Lecturer (Experimental Therapeutics)

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Pre-clinical study of Src kinase in primary and metastatic renal cancer.
    NHS Greater Glasgow and Clyde Endowment Funds
    2012 - 2013
     

Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2017 | 2016 | 2013
Number of items: 20.

2019

Roseweir, A. K. , Clark, J., McSorley, S. T. , vanWyk, H. C. , Quinn, J. A. , Horgan, P. G. , McMillan, D. C. , Park, J. H. and Edwards, J. (2019) The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer. International Journal of Cancer, 144(9), pp. 2320-2329. (doi:10.1002/ijc.32045) (PMID:30521130)

Andisha, N. M., McMillan, D. C. , Gujam, F. J.A., Roseweir, A. and Edwards, J. (2019) The relationship between phosphorylation status of focal adhesion kinases, molecular subtypes, tumour microenvironment and survival in patients with primary operable ductal breast cancer. Cellular Signalling, (Accepted for Publication)

Roseweir, A. K. , Powell, A. G.M.T., Horstman, S. L., Inthagard, J., Park, J. A. , McMillan, D. C. , Horgan, P. G. and Edwards, J. (2019) Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer. Cellular Signalling, 56, pp. 15-22. (doi:10.1016/j.cellsig.2019.01.007) (PMID:30684564)

Inthagard, J., Edwards, J. and Roseweir, A. K. (2019) Immunotherapy: enhancement the efficacy of this promising therapeutic in multiple cancers. Clinical Science, 133(2), pp. 181-193. (doi:10.1042/CS20181003) (PMID:30659159)

Roseweir, A.K. et al. (2019) A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with stage II/III colorectal cancer. International Journal of Cancer, 144(1), pp. 150-159. (doi:10.1002/ijc.31739) (PMID:29992570)

2018

Roseweir, A. K. , Clark, J., McSorley, S. T. , van Wyk, H. C. , Quinn, J. A. , Horgan, P. G. , McMillan, D. C. , Park, J. H. and Edwards, J. (2018) The association between markers of tumor cell metabolism, the tumor microenvironment and outcomes in patients with colorectal cancer. International Journal of Cancer, (Accepted for Publication)

Pennel, K. A.F. , Park, J. H. , McMillan, D. C. , Roseweir, A. K. and Edwards, J. (2018) Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: implications for treatment. Cellular Signalling, (doi:10.1016/j.cellsig.2018.11.013) (PMID:30453014) (Early Online Publication)

Roseweir, A. K. , McMillan, D. C. and Edwards, J. (2018) Reply to comment of "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer". British Journal of Cancer, 119(7), p. 909. (doi:10.1038/s41416-018-0275-7) (PMID:30297771)

Lua, J., Qayyum, T., Edwards, J. and Roseweir, A. K. (2018) The prognostic role of the non-canonical nuclear factor-kappa B pathway in renal cell carcinoma patients. Urologia Internationalis, 101(2), pp. 190-196. (doi:10.1159/000489816) (PMID:30089311)

Roseweir, A. K. , Halcrow, E. S., Chichilo, S., Powell, A. G.M.T., McMillan, D. C. , Horgan, P. G. and Edwards, J. (2018) ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer. British Journal of Cancer, 119, pp. 323-329. (doi:10.1038/s41416-018-0174-y) (PMID:29988110)

Roseweir, A. K. et al. (2018) Predictive biomarkers for endocrine therapy: retrospective study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial. Journal of the National Cancer Institute, 110(6), pp. 616-627. (doi:10.1093/jnci/djx255) (PMID:29917140)

Smith, J. T., Roseweir, A. , Millar, M., Clarke, I. and Millar, R. P. (2018) Stimulation of growth hormone by kisspeptin antagonists in ewes. Journal of Endocrinology, 237(2), pp. 165-173. (doi:10.1530/JOE-18-0074) (PMID:29549187)

Bilsland, A., Kelly, C., Roccisana, J., Paul, J. , Jones, R. , Edwards, J. , Roseweir, A. , Stein, T. and West, K. (2018) An Exploratory Study on the Use of Game-based Learning Using Microsoft Kinect to Teach Oncology Phase I Clinical Trial Designs. 2018 NCRI Cancer Conference, Glasgow, UK, 04-06 Nov 2018. (doi:10.1038/s41416-018-0299-z)

Sierra Gonzalez, P. et al. (2018) Mannose impairs tumour growth and enhances chemotherapy. Nature, 563, pp. 719-723. (doi:10.1038/s41586-018-0729-3) (PMID:30464341)

2017

Roseweir, A. K. , McCall, P., Scott, A., Liew, B., Lim, Z., Mallon, E. A. and Edwards, J. (2017) Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer. Oncotarget, 8(23), pp. 37172-37185. (doi:10.18632/oncotarget.16420) (PMID:28415597) (PMCID:PMC5514900)

Roseweir, A. K. , McMillan, D. C. , Horgan, P. G. and Edwards, J. (2017) Colorectal cancer subtypes: Translation to routine clinical pathology. Cancer Treatment Reviews, 57, pp. 1-7. (doi:10.1016/j.ctrv.2017.04.006) (PMID:28505475)

2016

Hatziieremia, S., Mohammed, Z., McCall, P., Willder, J. M., Roseweir, A. K. , Underwood, M. A. and Edwards, J. (2016) Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence. Molecular Carcinogenesis, 55(11), pp. 1667-1677. (doi:10.1002/mc.22417) (PMID:26495772)

Roseweir, A. K. , Powell, A. G.M.T., Bennett, L., Van Wyk, H. C. , Park, J. , McMillan, D. C. , Horgan, P. G. and Edwards, J. (2016) Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer. Oncotarget, 7(43), pp. 70601-70612. (doi:10.18632/oncotarget.12134) (PMID:27661110)

Roseweir, A. K. , Qayyum, T., Lim, Z., Hammond, R., MacDonald, A. I., Fraser, S., Oades, G. M., Aitchison, M., Jones, R. J. and Edwards, J. (2016) Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients. BMC Cancer, 16, p. 229. (doi:10.1186/s12885-016-2254-9) (PMID:26984511) (PMCID:PMC4794832)

2013

Roseweir, A. K. and Millar, R. P. (2013) Kisspeptin antagonists. In: Kisspeptin Signaling in Reproductive Biology. Series: Advances in Experimental Medicine and Biology, 784 (784). Springer New York: New York, NY, pp. 159-186. ISBN 9781461461982 (doi:10.1007/978-1-4614-6199-9_8)

This list was generated on Tue Jul 23 16:13:48 2019 BST.
Number of items: 20.

Articles

Roseweir, A. K. , Clark, J., McSorley, S. T. , vanWyk, H. C. , Quinn, J. A. , Horgan, P. G. , McMillan, D. C. , Park, J. H. and Edwards, J. (2019) The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer. International Journal of Cancer, 144(9), pp. 2320-2329. (doi:10.1002/ijc.32045) (PMID:30521130)

Andisha, N. M., McMillan, D. C. , Gujam, F. J.A., Roseweir, A. and Edwards, J. (2019) The relationship between phosphorylation status of focal adhesion kinases, molecular subtypes, tumour microenvironment and survival in patients with primary operable ductal breast cancer. Cellular Signalling, (Accepted for Publication)

Roseweir, A. K. , Powell, A. G.M.T., Horstman, S. L., Inthagard, J., Park, J. A. , McMillan, D. C. , Horgan, P. G. and Edwards, J. (2019) Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer. Cellular Signalling, 56, pp. 15-22. (doi:10.1016/j.cellsig.2019.01.007) (PMID:30684564)

Inthagard, J., Edwards, J. and Roseweir, A. K. (2019) Immunotherapy: enhancement the efficacy of this promising therapeutic in multiple cancers. Clinical Science, 133(2), pp. 181-193. (doi:10.1042/CS20181003) (PMID:30659159)

Roseweir, A.K. et al. (2019) A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with stage II/III colorectal cancer. International Journal of Cancer, 144(1), pp. 150-159. (doi:10.1002/ijc.31739) (PMID:29992570)

Roseweir, A. K. , Clark, J., McSorley, S. T. , van Wyk, H. C. , Quinn, J. A. , Horgan, P. G. , McMillan, D. C. , Park, J. H. and Edwards, J. (2018) The association between markers of tumor cell metabolism, the tumor microenvironment and outcomes in patients with colorectal cancer. International Journal of Cancer, (Accepted for Publication)

Pennel, K. A.F. , Park, J. H. , McMillan, D. C. , Roseweir, A. K. and Edwards, J. (2018) Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: implications for treatment. Cellular Signalling, (doi:10.1016/j.cellsig.2018.11.013) (PMID:30453014) (Early Online Publication)

Roseweir, A. K. , McMillan, D. C. and Edwards, J. (2018) Reply to comment of "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer". British Journal of Cancer, 119(7), p. 909. (doi:10.1038/s41416-018-0275-7) (PMID:30297771)

Lua, J., Qayyum, T., Edwards, J. and Roseweir, A. K. (2018) The prognostic role of the non-canonical nuclear factor-kappa B pathway in renal cell carcinoma patients. Urologia Internationalis, 101(2), pp. 190-196. (doi:10.1159/000489816) (PMID:30089311)

Roseweir, A. K. , Halcrow, E. S., Chichilo, S., Powell, A. G.M.T., McMillan, D. C. , Horgan, P. G. and Edwards, J. (2018) ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer. British Journal of Cancer, 119, pp. 323-329. (doi:10.1038/s41416-018-0174-y) (PMID:29988110)

Roseweir, A. K. et al. (2018) Predictive biomarkers for endocrine therapy: retrospective study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial. Journal of the National Cancer Institute, 110(6), pp. 616-627. (doi:10.1093/jnci/djx255) (PMID:29917140)

Smith, J. T., Roseweir, A. , Millar, M., Clarke, I. and Millar, R. P. (2018) Stimulation of growth hormone by kisspeptin antagonists in ewes. Journal of Endocrinology, 237(2), pp. 165-173. (doi:10.1530/JOE-18-0074) (PMID:29549187)

Sierra Gonzalez, P. et al. (2018) Mannose impairs tumour growth and enhances chemotherapy. Nature, 563, pp. 719-723. (doi:10.1038/s41586-018-0729-3) (PMID:30464341)

Roseweir, A. K. , McCall, P., Scott, A., Liew, B., Lim, Z., Mallon, E. A. and Edwards, J. (2017) Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer. Oncotarget, 8(23), pp. 37172-37185. (doi:10.18632/oncotarget.16420) (PMID:28415597) (PMCID:PMC5514900)

Roseweir, A. K. , McMillan, D. C. , Horgan, P. G. and Edwards, J. (2017) Colorectal cancer subtypes: Translation to routine clinical pathology. Cancer Treatment Reviews, 57, pp. 1-7. (doi:10.1016/j.ctrv.2017.04.006) (PMID:28505475)

Hatziieremia, S., Mohammed, Z., McCall, P., Willder, J. M., Roseweir, A. K. , Underwood, M. A. and Edwards, J. (2016) Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence. Molecular Carcinogenesis, 55(11), pp. 1667-1677. (doi:10.1002/mc.22417) (PMID:26495772)

Roseweir, A. K. , Powell, A. G.M.T., Bennett, L., Van Wyk, H. C. , Park, J. , McMillan, D. C. , Horgan, P. G. and Edwards, J. (2016) Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer. Oncotarget, 7(43), pp. 70601-70612. (doi:10.18632/oncotarget.12134) (PMID:27661110)

Roseweir, A. K. , Qayyum, T., Lim, Z., Hammond, R., MacDonald, A. I., Fraser, S., Oades, G. M., Aitchison, M., Jones, R. J. and Edwards, J. (2016) Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients. BMC Cancer, 16, p. 229. (doi:10.1186/s12885-016-2254-9) (PMID:26984511) (PMCID:PMC4794832)

Book Sections

Roseweir, A. K. and Millar, R. P. (2013) Kisspeptin antagonists. In: Kisspeptin Signaling in Reproductive Biology. Series: Advances in Experimental Medicine and Biology, 784 (784). Springer New York: New York, NY, pp. 159-186. ISBN 9781461461982 (doi:10.1007/978-1-4614-6199-9_8)

Conference or Workshop Item

Bilsland, A., Kelly, C., Roccisana, J., Paul, J. , Jones, R. , Edwards, J. , Roseweir, A. , Stein, T. and West, K. (2018) An Exploratory Study on the Use of Game-based Learning Using Microsoft Kinect to Teach Oncology Phase I Clinical Trial Designs. 2018 NCRI Cancer Conference, Glasgow, UK, 04-06 Nov 2018. (doi:10.1038/s41416-018-0299-z)

This list was generated on Tue Jul 23 16:13:48 2019 BST.